IO Insights

View in Browser March 27, 2025 Advertisement NEWS FROM SIO Apply by 7 April 2025: SIO Research Grants on Lipiodol and Immunotherapy Planning to submit an application for the open grants call? Now is the time! SIO, in collaboration with Guerbet, is seeking research proposals on Lipiodol-mediated locoregional delivery of immunotherapeutics. This is your opportunity to drive innovation in interventional oncology and advance the use of Lipiodol as a carrier for locoregional, image-guided immunotherapy delivery to solid tumors. View the eligibility requirements and learn more about the application procedures by visiting the SIO website. The deadline to submit your proposal is 7 April 2025. Grant recipients will be selected in Spring 2025. Learn More Advertisement Register for the First RMSS Talk of the Season in 2025! RMSS Talk of the Season #1: SIO Resident Research Panel - Featuring SIO Abstract Presenters Join the SIO Resident and Medical Student Section (RMSS) for the first lecture of their 2025 Talk of the Season Series on Tuesday, 8 April, at 8 p.m. ET. This lecture will feature early-career abstract presenters from the SIO 2025 Annual Scientific Meeting. Hear from your esteemed peers as they overview their ongoing research and provide valuable insights on how to balance research projects as trainees. Register Now Secure Your Spot for the SIO NEXT Summit Explore the future of immunotherapies and combination therapies at the NEXT Summit: Novel Explorations in Combination Therapies, taking place in Chicago, 5-6 June 2025. This in-person, multidisciplinary event is being hosted in partnership with both the International Liver Cancer Association (ILCA) and the Society for Immunotherapy of Cancer (SITC). Physicians, industry and multidisciplinary partners are invited to attend. Participants will unlock complimentary access to SITC's Advances in Cancer Immunotherapy (ACI) program as well as ILCA’s Single Topic Workshop: Emerging Role of Y90. As an additional incentive, practicing physicians can add an MDT partner for free when they register. SIO is also offering a limited number of scholarships to early career physicians and trainees, with priority given to PGY-5 and PGY-6 applicants. Recipients will receive complimentary registration for the two-day NEXT Summit, including access to SITC's ACI program and ILCA's Single Topic Workshop, a stipend of $750 to offset travel costs, and complimentary SIO membership for 2025. Submit your application. Register Now Advertisement Save the Date for Our Upcoming Webinars From management of RCC to emerging trends for lung treatment, SIO has your educational needs covered with these upcoming webinars! Don't miss the chance to expand your knowledge and stay ahead in the rapidly evolving field of oncology. Tuesday, 8 April - RMSS Talk of the Season #1: SIO Resident Research Panel - Featuring SIO Abstract Presenters, 8 p.m ET Wednesday, 21 May - SIO Emerging Trends in Lung, 7 p.m. ET Tuesday, 10 June - Percutaneous Ablation of Non-Renal Tumors, 6:30 p.m. ET Register Now 2025 Membership is Waiting for You — Rejoin Here! If you forgot to renew your membership for 2025, now is the time to rejoin! Don't miss out on valuable membership benefits—rejoin today to continue enjoying all the perks and opportunities SIO has to offer. Unsure which membership you qualify for? View our membership descriptions here to find the one that's right for you. If you're still unsure, feel free to email us at info@sio-central.org Follow the steps below to renew your membership now: Select "login" in the upper right corner of the SIO website Select "Set Up an Account." Enter your name and email address on record with SIO. Enter a new password. You will receive a "Verify your email" message to your inbox. Click the link to verify. A welcome message from SIO will be sent to your inbox to access your new SIO Portal. If you're having trouble finding the email, we recommend searching for "SIO" in your inbox. Reactivate Your Membership Hassle-Free Renewal! Choose our auto-renew option and never worry about your membership expiring. Just set it and forget it. Advertisement INDUSTRY NEWS Hepatobiliary Phase MRI-Guided Radiofrequency Ablation of Small Hepatocellular Carcinomas Invisible on Precontrast MRI European Journal of Radiology via ScienceDirect The study investigates the feasibility, technical success rate and safety of hepatobiliary phase MRI-guided percutaneous radiofrequency ablation for small hepatocellular carcinomas in cirrhotic livers. Read More Overall Survival Is Comparable Between Percutaneous Radiofrequency Ablation and Liver Resection as First-Line Therapies for Solitary 3-5 CM Hepatocellular Carcinoma Langenbeck's Archives of Surgery via Springer Nature Link A retrospective study comparing liver resection and percutaneous radiofrequency ablation for treating solitary 3-5 cm hepatocellular carcinoma aimed to clarify the issue. Read More Advertisement OPuS One Clinical Study News Promoted by Medtronic Outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System from the OPuS One trial were recently published in the November edition of the Journal of Vascular and Interventional Radiology (JVIR). Learn more about the largest prospective study in radiofrequency ablation for bone metastases. Read More Theranostic Radionuclides Labeled Biodegradable Microspheres for the Treatment of Hepatocellular Carcinoma With Radioembolization Radiation Physics and Chemistry via ScienceDirect Liver cancer, primarily hepatocellular carcinoma, is a leading cause of cancer-related deaths worldwide. Transarterial radioembolization offers a viable treatment option, but challenges persist. Read More IO Insights The Society of Interventional Oncology 2001 K Street NW, 3rd Floor North | Washington, DC 20006 USA 202-367-1164 | Contact Us www.sio-central.org Mykaila Potts Content Editor, Multiview 972-910-6876 | Contact me Unsubscribe | Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE | SUBSCRIBE | PAST ISSUES Published by